FDA authorizes the emergency use of Gilead's remdesivir in Covid-19 patients after researchers reported it shortened recovery times
WASHINGTON—The Food and Drug Administration authorized the emergency use of the drug remdesivir in Covid-19 patients after researchers reported that it shortened the recovery times in people who have fallen ill from the new coronavirus.
The FDA action limits the use of the drug, produced by Gilead Sciences Inc., for only through the duration of the pandemic, but health regulators could grant full approval if more benefits emerge from a large study by the National Institute of Allergy and Infectious Diseases and other clinical...
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
FDA authorizes emergency use of coronavirus drug remdesivirThe FDA has issued an emergency use authorization for remdesivir to help patients get quicker access to the first antiviral showing promise against Covid-19 infections
続きを読む »
FDA authorizes remdesivir drug as emergency treatment for COVID-19The U.S. Food and Drug Administration (FDA) has granted authorization to Gilead Sciences Inc for emergency use of its experimental antiviral drug remdesivir to treat patients with COVID-19, it said in a letter to Gilead.
続きを読む »
Data on Gilead drug raises hopes in pandemic fight, Fauci calls it 'highly significant'The top U.S. infectious disease official said Gilead Sciences Inc's experimental antiviral drug remdesivir will become the standard of care for COVID-19 after early results from a key clinical trial on Wednesday showed it helped patients recover more quickly from the illness caused by the coronavirus.
続きを読む »
Fauci says leak concerns fueled his White House revelation of Gilead drug resultsConcerns over leaks compelled the top U.S. infectious disease official to reveal data on Gilead Sciences Inc’s experimental drug remdesivir, the first in a scientifically rigorous clincial trial to show benefit in treating COVID-19.
続きを読む »
Gilead CEO on remdesivir: manufacturing, pricing for coronavirus drug - Business InsiderGilead plans to spend up to $1 billion to ramp up manufacturing of its coronavirus treatment, but execs dodged Wall Street's questions about turning a profit
続きを読む »
Maker of coronavirus trial drug aims for wide distribution: Gilead CEOGilead Sciences , which manufactures remdesivir, is focused on making the experimental coronavirus drug accessible and affordable to as many people as possible once it is approved, Chief Executive Officer Daniel O'Day said on Friday.
続きを読む »